Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MARIYAM CHERRY

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1750726550
CMS profile
1635499
Location
LUFKIN, TX

General Payments · PY2018–2024

$1,374.07

  • Reported across 68 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$297.66

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $297.66 16

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $160.25 11
Teva Pharmaceuticals USA, Inc. $64.69 3
JAZZ PHARMACEUTICALS INC. $47.50 1
ACADIA Pharmaceuticals Inc $25.22 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $187.85 4
PY2019 $20.51 1
PY2020 $21.22 1
PY2021 $159.69 10
PY2022 $323.86 17
PY2023 $363.28 19
PY2024 $297.66 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $20.08 02/19/2024 Food and Beverage Undisputed 01/23/2026 1103456770 CMS
ABBVIE INC. $19.98 03/06/2024 Food and Beverage Undisputed 01/23/2026 1103456772 CMS
ABBVIE INC. $17.06 05/08/2024 Food and Beverage Undisputed 01/23/2026 1103456774 CMS
ABBVIE INC. $4.33 06/05/2024 Food and Beverage Undisputed 01/23/2026 1103456776 CMS
ABBVIE INC. $14.15 07/11/2024 Food and Beverage Undisputed 01/23/2026 1103456778 CMS
ABBVIE INC. $4.32 08/27/2024 Food and Beverage Undisputed 01/23/2026 1103456780 CMS
ABBVIE INC. $15.89 09/10/2024 Food and Beverage Undisputed 01/23/2026 1103456782 CMS
ABBVIE INC. $20.50 09/17/2024 Food and Beverage Undisputed 01/23/2026 1103456784 CMS
ABBVIE INC. $17.77 09/30/2024 Food and Beverage Undisputed 01/23/2026 1103456786 CMS
ABBVIE INC. $19.96 11/20/2024 Food and Beverage Undisputed 01/23/2026 1103456788 CMS
ABBVIE INC. $6.21 12/05/2024 Food and Beverage Undisputed 01/23/2026 1103456790 CMS
ACADIA Pharmaceuticals Inc $25.22 09/03/2024 Food and Beverage Undisputed 01/23/2026 1147966282 CMS
JAZZ PHARMACEUTICALS INC. $47.50 07/26/2024 Food and Beverage Undisputed 01/23/2026 1150230811 CMS
Teva Pharmaceuticals USA, Inc. $25.45 08/22/2024 Food and Beverage Undisputed 01/23/2026 1151594519 CMS
Teva Pharmaceuticals USA, Inc. $24.43 09/11/2024 Food and Beverage Undisputed 01/23/2026 1151594521 CMS
Teva Pharmaceuticals USA, Inc. $14.81 10/24/2024 Food and Beverage Undisputed 01/23/2026 1151594557 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.